产品名称 | NebuSelect™ Recombinant Human Complement Component C2, His-tag |
---|---|
目录号 | NBL-242982 |
别名 | Complement Component C2; Complement C2; C3/C5 convertase; C2; ARMD14; CO2 |
外观 | see COA |
分子量 | Ala21-Leu752 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P06681-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242982-100ug | 100ug | Inquire | Inquire | |
NBL-242982-1mg | 1mg | Inquire | Inquire | |
NBL-242982-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Complement Component C2, His-tag
Catalog#:
NBL-242982
Description:
NebuSelect™ Recombinant Human Complement Component C2, His-tag(Cat#NBL-242982) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala21-Leu752.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 82.2 kDa (Pro form). Due to glycosylation, the protein migrates to 83-90 kDa (Pro form) based on Bis-Tris PAGE result.
Target Name:
Complement Component C2; Complement C2; C3/C5 convertase; C2; ARMD14; CO2
Target Information:
Single nucleotide polymorphism (SNP) of complement component 2 (C2) has been found to be significantly associated with hepatocellular carcinoma (HCC). Significantly lower C2 expression was found at HCC compared to healthy controls, and C2 was associated with TNM stages. Higher C2 expression was significantly associated with better prognosis, and multivariate analysis showed that C2 was also an independent factor for the prognosis of HCC.
Amino Acid Sequence:
Ala21-Leu752
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.